title: NTN Swiss Biotech - A Look at Support Measures for Dynamic Start-ups.
abstract: The Swiss biotech landscape seems to be on a healthy footing: There are many imaginative start-ups, we have first-class hospitals, highly advanced clinical research and the availability of a great deal of capital. But we have no reason to rest on our laurels as countries like the USA lead the field. We must lay down the tracks today to remain an attractive country and maintain our ranking among the 10 best locations.
authors.affiliation: Journalist science + technology.
authors.forename: Elsbeth
authors.initials: E
authors.lastname: Heinzelmann
mesh_terms: D001709:Biotechnology / Q000639:trends*; D004345:Drug Industry / Q000639:trends; D013557:Switzerland